CVS HEALTH CORPORATION Deferred Income Tax Expense (Benefit)
CVS HEALTH CORPORATION (CVS) reported Deferred Income Tax Expense (Benefit) of $102.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-10
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for the quarter ending 2011-12-31 was -$21.00M.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for the quarter ending 2011-09-30 was $5.00M, a 92.06% decline year-over-year.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for the quarter ending 2011-06-30 was $59.00M.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for the quarter ending 2011-03-31 was $70.00M, a 3400.00% increase year-over-year.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for fiscal 2025 was $102.00M.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for fiscal 2024 was -$572.00M.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for fiscal 2023 was -$676.00M.
- CVS HEALTH CORPORATION deferred income tax expense (benefit) for fiscal 2022 was -$2.03B.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $102.00M 10-K · filed 2026-02-10 | ||||||
| 2024-12-31 | -$572.00M 10-K · filed 2026-02-10 | ||||||
| 2023-12-31 | -$676.00M 10-K · filed 2026-02-10 | ||||||
| 2022-12-31 | -$2.03B 10-K · filed 2025-02-12 | -$2.08B 10-K · filed 2023-02-08 | |||||
| 2021-12-31 | -$402.00M 10-K · filed 2024-02-07 | -$428.00M 10-K · filed 2022-02-09 | |||||
| 2020-12-31 | -$564.00M 8-K · filed 2023-05-25 | ||||||
| 2019-12-31 | -$649.00M 10-K · filed 2022-02-09 | ||||||
| 2018-12-31 | $23.00M 10-K · filed 2021-02-16 | ||||||
| 2017-12-31 | -$1.42B 10-K · filed 2020-02-18 | ||||||
| 2016-12-31 | $3.00M 8-K · filed 2019-08-08 | ||||||
| 2015-12-31 | -$234.00M 10-K · filed 2018-02-14 | ||||||
| 2014-12-31 | -$43.00M 10-K · filed 2017-02-09 | ||||||
| 2013-12-31 | -$132.00M 10-K · filed 2016-02-09 | ||||||
| 2012-12-31 | -$200.00M 10-K · filed 2015-02-10 | -$195.00M 10-K · filed 2013-02-15 | |||||
| 2011-12-31 | -$21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | -$16.00M derived: sum of 2 quarters · filed 2014-02-11 | $43.00M derived: sum of 3 quarters · filed 2014-02-11 | $113.00M 10-K · filed 2014-02-11 | |||
| 2011-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $64.00M derived: sum of 2 quarters · filed 2011-11-03 | $134.00M 10-Q · filed 2011-11-03 | $42.00M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $59.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $129.00M 10-Q · filed 2011-08-04 | $37.00M derived: sum of 3 quarters · filed 2013-02-15 | $100.00M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $70.00M 10-Q · filed 2011-05-05 | -$22.00M derived: sum of 2 quarters · filed 2013-02-15 | $41.00M derived: sum of 3 quarters · filed 2013-02-15 | $19.00M derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | -$92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$29.00M derived: sum of 2 quarters · filed 2013-02-15 | -$51.00M derived: sum of 3 quarters · filed 2013-02-15 | -$49.00M 10-K · filed 2013-02-15 | $30.00M 10-K · filed 2011-02-18 | ||
| 2010-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $41.00M derived: sum of 2 quarters · filed 2011-11-03 | $43.00M 10-Q · filed 2011-11-03 | $16.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | -$22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$20.00M 10-Q · filed 2011-08-04 | -$47.00M derived: sum of 3 quarters · filed 2012-02-17 | -$39.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $2.00M 10-Q · filed 2011-05-05 | -$25.00M derived: sum of 2 quarters · filed 2012-02-17 | -$17.00M derived: sum of 3 quarters · filed 2012-02-17 | $10.00M derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | -$27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | -$19.00M derived: sum of 2 quarters · filed 2012-02-17 | $8.00M derived: sum of 3 quarters · filed 2012-02-17 | $42.00M 10-K · filed 2012-02-17 | $48.00M 10-K · filed 2010-02-26 | ||
| 2009-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $35.00M derived: sum of 2 quarters · filed 2010-11-03 | $69.00M 10-Q · filed 2010-11-03 | $69.90M 10-Q · filed 2009-11-05 | $41.90M derived: sum of 4 quarters · filed 2011-02-18 | ||
| 2009-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-29 | $61.00M 10-Q · filed 2010-07-29 | $60.90M 10-Q · filed 2009-08-04 | $33.90M derived: sum of 3 quarters · filed 2011-02-18 | $66.10M derived: sum of 4 quarters · filed 2011-02-18 | ||
| 2009-03-31 | $34.00M 10-Q · filed 2010-05-04 | $6.90M derived: sum of 2 quarters · filed 2011-02-18 | $39.10M derived: sum of 3 quarters · filed 2011-02-18 | ||||
| 2008-12-31 | -$27.10M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $5.10M derived: sum of 2 quarters · filed 2011-02-18 | -$3.00M 10-K · filed 2011-02-18 | ||||
| 2008-09-27 | $32.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $24.10M 10-Q · filed 2009-11-05 | |||||
| 2008-06-28 | -$8.10M 10-Q · filed 2009-08-04 | ||||||
| 2007-12-29 | $39.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |